Skip to content

LISA vs INSURE in Extremely Low Birth Weight Infants. A Manikin Study

Does LISA Change the Time of Device Positioning Compared to INSURE in Extremely Low Birth Weight Infants With RDS? A Crossover Randomized Controlled Manikin Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04944108
Enrollment
42
Registered
2021-06-29
Start date
2021-12-16
Completion date
2022-01-14
Last updated
2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Birth, Respiratory Distress Syndrome, Surfactant Deficiency Syndrome Neonatal

Brief summary

This is an unblinded, randomized, controlled, crossover (AB/BA) trial of surfactant treatment with LISA vs. INSURE in a manikin simulating an extremely low birth weight infant. Participants will be level III NICU consultants and residents. Randomization will be performed using a computer-generated random assignment list. The primary outcome measure will be the total time of device positioning. The secondary outcomes will be the success of the first and the participant's satisfaction.

Detailed description

Background: Although LISA offers some advantages in ventilation procedure and neonatal outcomes over INSURE, the use of a catheter during LISA may have some drawbacks such as the prolonged duration of the laryngoscopy needed to insert the device. This is likely to aggravate the invasiveness of the procedure, resulting in stressful consequences such as bradycardia, hypoxia and hemodynamic changes. Objectives: i) time of device positioning, ii) success of the procedure of positioning the device, iii) participant's satisfaction. Methods: This is an unblinded, randomized, controlled, crossover (AB/BA) trial of surfactant treatment with LISA vs. INSURE in a manikin simulating an extremely low birth weight infant. Participants will be level III NICU consultants and residents. Randomization will be performed using a computer-generated random assignment list. The primary outcome measure will be the total time of device positioning. The secondary outcomes will be the success of the first and the participant's satisfaction.

Interventions

PROCEDURELISA approach

Participants will be randomized to administer surfactant in a preterm manikin by using the LISA approach (thin catheter) or the INSURE approach (tracheal tube)

PROCEDUREInsure approach

Participants will be randomized to administer surfactant in a preterm manikin by using the INSURE approach (tracheal tube)

Sponsors

University Hospital Padova
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Level III NICU consultants and residents will be eligible to participate in the study.

Exclusion criteria

* There are no

Design outcomes

Primary

MeasureTime frameDescription
Time of device positioning10 minutesTime needed for the correct positioning of the device into the trachea (thin catheter or tracheal tube). In case of failure, total time will be the sum of time of all attempts.

Secondary

MeasureTime frameDescription
Success of the procedure at the first attempt1 minuteIt refers at the success of the device positioning during the first attempt
Participant's satisfaction5 minutesAt the end of the procedure, all participants will be required to fill a 5-item questionnaire aimed to assess their perception on the procedure (Likert scale)
Number of attempts to insert the device in the trachea10 minutesIt refers to the number of attempts to insert the device in the trachea
Correct depth of the device in the trachea10 minutesIt refers to reaching the correct depth in the trachea as assessed by the external observer using a laryngoscope

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026